ACC: Ionis' rare metabolic disorder drug slides from 100% efficacy, but FDA ambitions...

[cafead]

via Ionis Pharmaceuticals previously touted that olezarsen was 100% effective in a rare metabolic disorder after a phase 3 readout. Now, the full data set is slightly denting that statistic while leaving plenty of room for a planned regulatory filing later this year.

article source